How Private Equity Oversees the Ethics of Drug Research

The oversight of drug research by private equity firms is raising significant concerns about ethics and patient safety. Many trials are conducted by companies that have close ties to the drugmakers, which can lead to conflicts of interest. This situation is troubling because it may compromise the integrity of the research and ultimately affect patient outcomes. It's crucial for the industry to address these issues to ensure that drug development is conducted transparently and safely.